TRAWS PHARMA INCORPORATED (TRAW)

T. Rowe Price Group (NASDAQ:TROW) reported second-quarter 2026 adjusted diluted earnings per share of $2.57, up from $2.52 in the first quarter and $2.24 a year earlier, as higher average assets under management and investment advisory revenue outweighed increased expenses. The asset manager ended

Although the revenue and EPS for T. Rowe (TROW) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Earnings call transcript: T. Rowe Price tops Q2 2026 estimates but shares slip

T. Rowe Price (NASDAQ:TROW) Misses Q2 CY2026 Revenue Estimates

T. Rowe (TROW) delivered earnings and revenue surprises of +1.98% and -0.60%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?